GO
Loading...

Onyx rejects $10 billion bid from Amgen

Monday, 1 Jul 2013 | 6:25 PM ET

Onyx Pharmaceuticals is seeking out more competitive offers beyond Amgen's $10 billion takeover bid. "Mad Money" host Jim Cramer says there are better opportunities in the biotech space right now.